The epidermal growth factor receptor (EGFR) has been targeted for inhibition using tyrosine kinase inhibitors and monoclonal antibodies. with improvement in outcome in subsets of patients with head and neck. lung. and colorectal carcinomas. https://www.markymarkscott.com/product-category/bacon/